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Background: Regulatory T cells (Tregs) are a subset of T cells that play an important role in modulating T effector
responses during infectious challenges. The aim of this study was to evaluate possible associations between
regulatory gene polymorphisms and the risk of uncomplicated malaria and the control of Plasmodium falciparum
parasite density levels.
Methods: Twelve regulatory single nucleotide polymorphisms (SNPs) in the promoter regions of FOXP3
(ss270137548, rs11091253), IL10RA (rs56356146, rs7925112), IL10RB (rs8178433, rs8178435, rs999788), STAT6
(rs3024941, rs3024943, rs3024944) and TNFRSF18 (ss2080581728, rs3753344) were genotyped in a cohort of
Congolese children. Studied subjects were followed up (passively) during one year. The children who experienced
one or several clinical episodes were genotyped as “uncomplicated malaria” group (n=179) and those children who
did not experience any episode were genotyped as “asymptomatic children” group (n=138).
Results: The prevalence of rs3024944CC genotype of STAT6 was significantly higher in the group of asymptomatic
children compared to that of uncomplicated malaria (P=0.003). Similarly, the minor allele rs3024944C was more
prevalent in the group of asymptomatic children (P=0.019). Two novel SNPs were observed including -163T/G
(ss491228441) in IL10RA gene and -163C/T (ss491228440) in TNFRSF18 gene. The genotype ss491228441TT and the
minor allele ss491228441G of the IL10RA were more frequent in the group of asymptomatic children (P=0.006 and
P=0.007, respectively). The genotype rs11091253CT of the FOXP3 was associated with high parasite density levels. In
addition, a new promoter IL10RA variant (ss491228441) contributes to shield against mild malaria.
Conclusion: The study indicated that the STAT6 promoter polymorphism rs3024944 was associated with
uncomplicated malaria, whereas the FOXP3 promoter variant rs11091253 was associated with significant P.
falciparum parasitaemia levels. These genetic data may contribute to the understanding of molecular mechanisms
that regulate immune response to P. falciparum infections.
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Malaria is one of the major causes of morbidity and
mortality in tropical and sub-tropical areas. Approxi-
mately 216 million clinical cases of malaria occurred
worldwide in 2010, resulting in almost 655,000 deaths
[1]. Sub-Saharan Africa remains the region with the
highest burden of the disease, accounting for nearly 91%
of global malaria deaths. Malaria is caused by protozoan
parasites of the genus Plasmodium and Plasmodium fal-
ciparum being the most virulent species. Plasmodium
falciparum-infected individuals show different clinical
phenotypes, which range from asymptomatic infections
to severe forms of malaria [1]. Several investigations
demonstrated that immune gene polymorphisms in
human host, such as those having an impact on expres-
sion of T regulatory cells (Treg), contribute to the vari-
ability of malaria phenotypes [2,3]. The generation of
Tregs has been demonstrated to modulate the immune
response in malaria infection as well as in other infec-
tious diseases [4-8]. A few of the Tregs are induced in
response to infectious challenge and the others are con-
sidered as natural regulators [4]. Expression of Tregs is
well known to be regulated by number of human host
genes, such as the forkhead box P3 (FOXP3), interleukin
10 receptors alpha and beta (IL10RA and IL10RB), the
signal transducer and activator of transcription 6
(STAT6), and the tumour necrosis factor receptor super-
family member 18 (TNFRSF18) [9].
FOXP3 belongs to the family of transcription factors
that play a role in various cellular processes and is
described as an important regulator of natural Tregs de-
velopment and function [10-12]. In humans, mutations
in the FOXP3 gene are known to be associated with im-
mune dysregulation polyendocrinophathy and enteroph-
athy X-linked syndrome (IPEX) caused by lack of Tregs
[13]. IL10RA and IL10RB are two receptor chains form-
ing the human interleukin 10-receptor (IL10R) which
belongs to the class II cytokine receptors [14]. The
major role of IL10RA precursor is to mediate high affin-
ity and ligand binding and subsequent signal transduc-
tion, whereas the IL10RB precursor is believed to
contribute only in signalling process [15]. Reports have
demonstrated that mutations in the genes encoding
IL10RA and IL10RB precursors of the IL10R annul the
IL10 mediated immunomodulatory signalling and are
strongly associated with inflammatory bowel disorders
[16]. Recently combined promoter haplotypes of the
IL10RA and IL10RB genes have been shown to be asso-
ciated with protection against severe malaria in Gabon-
ese children [14]. The STAT6 gene, which belongs to the
STAT family of transcription factors, has been reported
to mediate various cytokine-induced responses. Recent
reports have shown that STAT6 gene polymorphisms
play crucial roles in controlling helminth infection. Moreprecisely, a promoter variant rs324013 was found to be
associated with the control of Schistosoma haematobium
in a Dogon population (where S. haematobium is en-
demic) in Mali [17]. Similarly, the variant rs324015 was
associated to the control of infection levels in Chinese
children from an endemic area for Ascaris lumbricoides
[18]. TNFRSF18, also known as glucocorticoid-induced
TNF receptor, is a member of TNF superfamily, which
plays a key role in the co-stimulatory process for T cell
activation for both conventional and CD25+CD4+ T cells.
In addition, TNFRSF18 expressed on Tregs was demon-
strated to play a crucial role in the maintenance of per-
ipheral tolerance [9]. Therefore, all these findings
suggest that mutations in FOXP3, IL10RA, IL10RB,
STAT6 and TNFRSF18 may lead to various immuno-
pathological reactions in auto-immune disorders and/or
parasitic infections.
In a previous investigation, regulatory SNPs in the
promoter region of FOXP3, IL10RA, IL10RB, STAT6 and
TNFRSF18 genes were identified in the Gabonese popu-
lation in Central Africa. These identified SNPs were fur-
ther validated for their allelic gene expression using
transient transfection assays [14,19-21]. Against this
background, in the present study, the possible relation-
ship between the reported SNP variants and risk of
having uncomplicated P. falciparum malaria was investi-
gated. For this purpose, this study utilized a case-control
cohort of Congolese children, who were followed up
(passively) during one year for surveillance of clinical
malaria cases, comprising a group of children who
experienced one or several uncomplicated malaria epi-
sodes and that of children who had no clinical episode
during the follow up. As a second objective, the impact
of these SNPs carriage on the P.falciparum parasite
density levels was assessed.
Methods
Study area, study population and ethical consideration
The study was carried out in three districts (Kinsana,
Mbouono and Ngoko) of Makélékélé health division in
the southern area of Brazzaville. These districts are
semi-urban with about 6,000 inhabitants and located
along the Congo River. Malaria is transmitted through-
out the year with P. falciparum being the predominant
species and Anopheles gambiae the main mosquito vec-
tor [9]. This study, as part of a cohort study for malaria
surveillance in the study area (Ndounga et al, unpub-
lished), is a community-based case-control study. The
study population consisted of children aged one to nine
years permanently living in the study area. All the study
individuals belong to Bantu ethnicity and had equivalent
risk for infection. Children were recruited between April
and June 2010 and passively followed up during one
year. At the time of enrolment 4 ml of whole blood were
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smears were performed. The inclusion criteria were:
absence of clinical malaria in the previous two weeks
and one week after enrolment (an axillary temperature
of <37.5°C, no disease symptoms such as muscular pain
and headaches), negative thick blood smear or positive
blood smear with less than 5,000 parasites per microlitre
of blood (p/μl), and not being homozygous for sickle cell
trait. During the follow up, at any time, when a child was
suspected to have fever or any malaria-related symptoms,
parents or guardians were invited to present the child at
the health centre for clinical examination. In case of ma-
laria (positive thick and thin blood smears and axillary
temperature ≥37.5°C), blood sample was collected, para-
site density determined and children were treated with
artesunate-amodiaquine or artemether-lumefantrine. No
data were available about the present or past history of
helminth infection.
The ethical approval was given by the Institutional
Ethics Committee for Research on Health Sciences of
the Republic of Congo. Written informed consent was
obtained from parents or guardians of children.
Microscopic examination
Thick and thin blood films were stained with 10%
Giemsa for 15 min and read by two independent,
competent microscopists to determine the parasite den-
sity and Plasmodium species. Asexual parasites were
counted against 200 leucocytes and expressed as the
number of asexual parasites per μl, assuming the leuco-
cytes count of 8,000/μl of blood.
DNA extraction
Genomic DNA was extracted from 200 μl of peripheral
whole blood samples obtained from patients and asymp-
tomatic children using the commercially available QIAamp
DNA Blood Mini Kit (Qiagen, Hilden, Germany) following
the manufacturer’s instructions and stored at -20°C until
use.
SNP genotyping
The promoter region of each of the five targeted genes
in all the samples was genotyped for the promoter SNP
variants that revealed altered gene expression as
reported in earlier investigations. Those SNPs are:
-794C/G (ss270137548) and -738C/T (rs11091253), for
the FOXP3 gene; -185C/T (rs56356146), and -116T/C
(rs7925112) for the IL10RA gene; -978T/G (rs8178433),
-754A/G (rs8178435), and -740C/T (rs999788) for the
IL10RB gene; -3728C/G (rs3024941), -3430G/A
(rs3024943), and -3387G/C (rs3024944) for the STAT6
gene; and -265C/T (ss2080581728), and -199C/T
(rs3753344) for the TNFRSF18 gene. Polymerase chain
reaction (PCR) amplifications were carried out in 20 μlreaction volumes with 5 ng of genomic DNA, 1X PCR
buffer (20 mM of Tris-HCL pH 8.4, 50 mM of KCL, 1.5
mM of MgCl2), 0.2 mM of dNTPs, 0.5 mM of each pri-
mer and 1 U of Taq DNA polymerase (Qiagen, Hilden,
Germany). Thermal cycling parameters are mentioned in
Table 1. All the PCR products were purified with the
PCR DNA Purification Kit (GE Healthcare Europe
GmbH) and 1 μl of the purified product was directly
used as template for sequencing using the BigDye termi-
natorv.2.0 cycle sequencing Kit (Applied Biosystems,
USA) on an ABI 3130 DNA sequencer, according to the
manufacturer’s instructions. Sequence-specific primers
designed and used for amplifications and sequencing are
listed in Table 1. Polymorphisms were identified by
assembling the sequences with respective reference
sequences obtained from SNPper database using Codon
code Aligner 4.0 software and were reconfirmed visually
from their respective electropherograms.Statistical analysis
In this study, children without any reported malaria epi-
sode during the follow-up period were considered as
asymptomatic and were classified in a group as asymp-
tomatic children (as they could possibly be parasite car-
riers). Similarly, those who experienced at least one
clinical malaria attack were classified in another group
as uncomplicated malaria. Clinical and parasitological
data for each child who had uncomplicated malaria were
obtained from the longitudinal cohort study for malaria
surveillance (Ndounga et al, unpublished). Those data
included number of malaria attacks or episodes, parasite
density and axillary temperature values.
Statistical analysis was performed using binary logistic
regression model with Intercooled Stata v. 9.1 (STATA
Corporation, Texas, USA) to determine the differences
in allele frequencies and genotype distributions between
uncomplicated malaria and asymptomatic children
adjusted for age and gender. The level of significance
was set at P<0.05. In addition, genetic models such as al-
lelic, dominant and recessive were examined to evaluate
the contributions of the genotype and allele frequencies
using STATA. Kruskal-Wallis tests were employed to
analyse the relationship between genotype distributions
and the number of episodes as well as the risk of para-
site density levels in the group of children with uncom-
plicated malaria. Genotype or haplotype frequencies
were determined by simple gene counting and by using
the expectation-maximum (EM) algorithm. The signifi-
cance of deviation from Hardy-Weinberg equilibrium
was tested using the random-permutation procedure as
implemented in the Arlequin v. 3.5.1.2 software [22].
Linkage disequilibrium (LD) analysis was performed
using Haploview V. 3.2 program.
Table 1 Primers used for genotyping and sequencing
Gene ID Chr. Primer sequences (Forward/reverse) Size Thermal Conditions
FOXP3 X 50-AGGCTGAGGGCCTCAGAAGCATC-30* 429 bp 94°C(5mn), [94°C(15S), 61°C(1mn) 72°C(1mn)]x35, 72°C(10mn)
50-CTCCAGGCCTCAGTTTCCCTATAG-30
IL10RA 11 50-GGGAAGGAAAGGGAGGGGTGGC-30* 241 bp 94°C(2mn), [94°C(30S) 61°C(30S),72°C(30S)]x35, 72°C(2mn)
50-GCGCGCCTCCAGCTACCCTTG-30
IL10RB 21 50-AAGGATGAGGCTGTGAGGAGG-30* 401 bp 94°C(2mn), [94°C(30S) 61°C(30S),72°C(1mn)]x35, 72°C(2mn)
50-CAAGCAGAGGGAAGTGAATGCG-30
STAT6 12 50-GGCGTGTCTCAGTGTTTACCCC-30* 530 bp 94°C(2mn), [94°C(30S) 61°C(30S),72°C(1mn)]x30, 72°C(2mn)
50-GTCCCCCTCAAAAGCATCAGC-30
TNFRSF18 1 50-TCCATGGTTGAGGCTCTCTGG-30* 293 bp 94°C(2mn), [94°C(30S) 61°C(30S),72°C(1mn)]x35, 72°C(2mn)
50-GTGTGAGGAGGGGGTGTAGAC-30
Chr: Chromosome, *: Sequencing primers, bp: Base pairs, mn: minutes, S: seconds.
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Characteristics of the study participants
Of the 323 children enrolled in the cohort study for mal-
aria surveillance (Ndounga et al, personal communica-
tion), samples from 317 children were available for the
present study. All the 317 children were successfully fol-
lowed up during one year, and among them, 179 had at
least one clinical malaria episode (forming the group of
uncomplicated malaria children) whereas 138 did not
experience any clinical malaria (forming the group of
asymptomatic children). A total of 297 episodes were
recorded without any case of recrudescence. No case of
severe malaria was recorded and P. falciparum was the
only Plasmodium species detected in children with un-
complicated malaria. Characteristics of recruited chil-
dren are summarized in Table 2.
Contribution of regulatory gene polymorphisms to
uncomplicated clinical malaria
All the analysed SNPs did not deviate from Hardy-
Weinberg equilibrium in each group. Genotype distribu-
tions and allele frequencies of these SNP variants are
summarized in Table 3. Two novel SNPs were identified
in the promoter region of IL10RA at the position -163T/G
(ss491228441) and at the position -163C/T (ss491228440)
in the promoter region of TNFRSF18 gene, respectively.
The identified novel SNPS were submitted to the SNPper
database and appropriate SNP #ss IDs were received. The
new SNP IDs for -163T/G of IL10RA and -163C/TTable 2 Baseline characteristics of recruited children
Characteristics Mild malaria (n=179)
Mean age (year) 4.73 ± 2.51
Sex ratio (Male/Female) 1.16 (96/83)
Parasite carriers (%) 21 (11%)
Hb AA carries (%) 148 (82.69)
Hb SS carriers (%) 31 (17.31%)
Hb: haemoglobin; NS: non-significant; Unc malaria: uncomplicated malaria;
Asym: asymptomatic.variants are rs199832262 and rs150621809 respectively.
Association analysis revealed that genotype rs3024944CC
of STAT6 gene was observed more in children who did
not have clinical malaria episode during the follow up
(asymptomatic group) compared to uncomplicated ma-
laria group (Adjusted OR: 0.17, 95%CI: 0.05-0.55,
P=0.003). The minor allele rs3024944C of STAT6 gene
was associated with decreased risk of clinical uncompli-
cated malaria (Adjusted OR: 0.57, 95%CI: 0.35-0.91,
P=0.019). Interestingly, the heterozygous genotype
ss491228441TG of the IL10RA was also found to be more
frequent in asymptomatic children and the homozygous
ss491228441TT genotypes were observed to be a risk
factor (Adjusted OR: 6.35, 95%CI: 1.68-23.9, P=0.006).
Also it was revealed that the minor allele ss491228441G of
the IL10RA gene, despite it low overall frequency in Con-
golese children, was significantly more frequent in asymp-
tomatic children compared to uncomplicated malaria
group (Adjusted OR: 0.16, 95%CI: 0.04-0.61, P=0.007).
The other regulatory polymorphisms in the FOXP3,
IL10RB and TNFRSF18 loci do not reveal any significant
associations either at allele, genotype or at haplotype
levels.
The reconstructed haplotypes of STAT6 (rs3024941/
rs30240943/rs3024944) and IL10RA (rs56356146/rs7925
112/ss491228441) were observed as a susceptibility fac-
tor between both studied groups and are presented in
Table 4. In total, five different haplotypes were observed
for STAT6 locus, of which the major haplotype CGGAsym (n=138) P value





Table 3 Distribution of gene variants in children from the group of uncomplicated malaria and that of asymptomatic
children








TT 176 (0.98) 125 (0.91)
TG 3 (0.02) 13 (0.09)
GG 0 (0) 0 (0)
Allele
T 355 (0.99) 263 (0.95) Reference
G 3 (0.01) 13 (0.05) 0.16 (0.04-0.61) 0.007
Dominant
TT 176 (0.98) 125 (0.91) 6.35 (1.68-23.9) 0.006
TG+GG 3 (0.02) 13 (0.09)
Recessive
GG 0 (0) 0 (0) NA




GG 145 (0.81) 106 (0.77)
GC 30 (0.17) 17 (0.12)
CC 4 (0.02) 15 (0.11)
Allele
G 320 (0.89) 229 (0.82) Reference
C 38 (0.11) 47 (0.18) 0.57 (0.35-0.91) 0.019
Dominant
GG 145 (0.81) 106 (0.77) NS
GC+CC 34 (0.19) 32 (0.23)
Recessive
CC 4 (0.02) 15 (0.11) 0.17 (0.05-0.55) 0.003
GG+GC 175 (0.98) 123 (0.89)
NA: not applicable; NS: not significant; Unc malar: uncomplicated malaria; Asym: asymptomatic, Odds ratio and P value were calculated by using binary logistic
regression model and adjusted for age and gender.
Table 4 Distribution of STAT6 and IL10RA haplotypes









CGG 276 (0.771) 193 (0.699) 1.4 (1.0-2.0) 0.054
GAG 43 (0.121 36 (0.130) NA NS
CGC 38 (0.106) 43 (0.156) NA NS
CAG 1 (0.002) 0 (0) NA NS
GAC 0 (0) 3 (0.011) NA NS
CAC 0 (0) 1 (0.004) NA NS
IL10RA (rs56356146
/rs7925112 /ss491228441)
CTT 284 (0.8) 209 (0.758) NA NS
TTT 44 (0.12) 40 (0.145) NA NS
CCT 26 (0.07) 14 (0.05) NA NS
CTG 3 (0.008) 13 (0.047) 0.16
(0.04-0.61)
0.007
TCT 1 (0.002) 0 (0) NA NS
NA: not applicable; NS: not significant; Unc malar: uncomplicated malaria; Asym: asymptomatic, Odds ratio and P value were calculated by using binary logistic
regression model and adjusted for age and gender.
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children who presented at least one clinical episode
(uncomplicated malaria) (Adjusted OR: 1.4, 95%CI: 1.0-
2.0, P=0.05). Similarly, five haplotypes were observed for
the IL10RA, and the minor haplotype CTG was found to
be associated with protection against the disease
(Adjusted OR: 0. 16, 95%CI: 0.04-0.61, P=0.007). Diffe-
rent haplotypes of the other genes were not found to be
significantly distributed between both groups of chil-
dren. The linkage disequilibrium pattern of studied loci
in promoter regions of STAT6 and IL10RA are presented
in Figure 1.Contribution of regulatory gene polymorphisms to
clinical episodes and parasite density
The effects of each single SNP variant on the number of
clinical malaria episodes were investigated by simple
comparison of genotype and allele distributions between
individuals who experienced one malaria attack and
those who experienced two or more malaria attacks. No
association was found between the investigated SNPs
and the number of malaria attacks. However analyses of
the effect of individual single nucleotide polymorphisms
on parasite density levels (Kruskal-wallis tests) showed
an association between the FOXP3 rs11091253 variant
and P. falciparum parasitaemia. More precisely, patients
carrying the rs11091253CT genotype harboured higher
parasite densities compared to those carrying the
rs11091253CC or rs11091253TT genotype (Figure 2).
These results also showed that patients having the
STAT6 rs3024944CC genotype, which was correlated
with protection against uncomplicated malaria, were
found to have low levels of infection than those with G/
G (not significant) (Figure 3).Figure 1 Linkage disequilibrium of studied variants in asymptomatic
studied SNPs in promoter regions of STAT6 in uncomplicated malaria (A); S
(C); and, IL10RA in asymptomatic children (D). At the top, the SNPs are sho
gene. Empty squares indicate a high degree of LD (LD coefficient D’ = 1) b
indicate strong LD, purple and white squares indicate lower degree of LDDiscussion
Malaria has exerted selective pressure on the human ge-
nome that has led to changes, such as haemoglobin S
which confers some resistance against severe malaria [23].
Understanding the mechanisms leading to increased sus-
ceptibility or resistance against the disease would assist in
the elaboration of better tools to fight the disease. In this
search, immune responses that are on the front of the de-
fence are particularly investigated. Tregs are suggested to
be central in the control of P. falciparum infection. There-
fore, investigation of human polymorphisms in genes
associated with Treg activity may underlie both suscepti-
bility to infection and level of Treg expression.
The present study evaluated the contribution of pro-
moter SNPs of FOXP3, IL10RA, IL10RB, STAT6 and
TNFRSF18 genes in P. falciparum infection outcome
among Congolese children. Earlier studies have identi-
fied some regulatory SNPs on the promoter loci of these
five genes from 40 unrelated Gabonese individuals who
had earlier infection episodes with various parasites,
including P. falciparum [14,19-21]. These SNPs were
then validated for their allelic gene expression using
transient transfection assays. Some of the identified were
already pre-described, while others were newly disco-
vered. All the SNPs selected for the current investigation
were found to alter expression of their respective gene
[14,19-21]. Therefore any possible correlations of these
SNP variants with resistance or susceptibility to mild
malaria attacks and/or the control of P. falciparum in-
fection levels were evaluated.
The results obtained in this study demonstrated that
the STAT6 rs3024944C/C genotype was significantly
more prevalent in asymptomatic children. This suggests
the contribution of this genotype to protection of Con-
golese children against mild clinical malaria. The SNPand uncomplicated malaria. Linkage disequilibrium pattern of
TAT6 in asymptomatic children (B); IL10RA in uncomplicated malaria
wn according to their succession from the promoter region of studied
etween pairs of markers, numbers indicate the D’ value, red squares































Figure 2 Association of the FOXP3 rs11091253 SNP with parasite density levels. Note. P values were calculated by Kruskal-Wallis test.
Shown P values are corrected for multiple comparisons.
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site TCF-1 which is a member of family of genes with
homology to high mobility group I (HMG) proteins [24].
TCF-1, in part with β-catenin, plays a pivotal role in T
cell activation and is specifically expressed in T lympho-




































P value > 0.05
Figure 3 Association of rs3024944 of STAT6 and parasite
density levels. Note. P values were calculated by Kruskal-Wallis test.malaria group, children with the minor allele rs3024944C
have low parasite densities compared to those having the
major allele rs3024944G, that speculates that the
rs3024944C/C variant directs activation of T cells in re-
sponse to P. falciparum infection, thus contributing to
protection against the disease through parasite elimi-
nation. In haplotype level, the major haplotype CGG was
found to be correlated with the marginal risk of uncompli-
cated malaria. This emphasizes the role of the SNP
rs3024944 on susceptibly/resistance to uncomplicated
malaria among Congolese children. This is the first study
that shows the correlation between a promoter SNP
STAT6 rs3024944 and protection against uncomplicated
malaria. However, in previous investigations, the promoter
SNP rs324013 was found to be associated with the control
of S. haematobium infection levels in a Dogon population
in Mali [17]. Similarly, the variant rs324015 was associated
to the control of A. lumbricoides infection levels in
Chinese children [18].
Two novel promoter SNPs were identified including,
ss491228441 and ss491228440 of IL10RA and TNFRSF18
respectively. In both cases the frequency of the minor
allele was low. Meanwhile the minor allele ss491228441G
of IL10RA appeared to contribute to protection against
uncomplicated malaria. Interestingly, the haplotype CTG
involving this minor allele ss491228441G was significantly
more present in asymptomatic children. This provides an
additional evidence of the involvement of this allele in
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ever, larger association studies in different malaria en-
demic areas including children and adults as well as
functional studies of this ss491228441 SNP variant would
be of great interest to verify the current observations.
The data also showed the association between the
carriage of the FOXP3 rs11091253 SNP variant and P.
falciparum parasite density levels. In particular, the
rs11091253CT genotype was found to be associated with
high infection levels, whereas the homozygous for the
minor allele, the rs11091253TT genotype, was associated
with lower infection levels. This suggests that FOXP3
contributes to the modulation of the immune response
against P. falciparum infection. The SNP rs11091253 is
located in a putative binding site for the transcription
factors nuclear factor kappa B (NF-κB) and c-Rel, which
is also a member of NF-κB family. These transcription
factors have been demonstrated to be critical for regula-
tion and transcription of FOXP3 [27,28]. Therefore the
differential binding properties of the promoter carrying
the rs11091253CT genotype and that of the promoter
carrying the rs11091253TT genotype may explain the
associations observed in this study. One possible explan-
ation may be that the binding of NF-κB and/or c-Rel
with the promoter carrying the rs11091253C/T genotype
results in upregulation of FOXP3 which in turn leads to
increased number of fully functional Tregs. Conse-
quently, parasite multiplication is facilitated by suppres-
sion of either P. falciparum-responsive effector cells or
pro-inflammatory cytokine response. This is in line with
what was reported by previous study showing that upre-
gulation of FOXP3, and CD4+CD25+ regulatory cells
correlates with more rapid parasite growth in human
malaria infection [7].
Conclusion
To summarize, selected regulatory SNPs in the promoter
region of FOXP3, IL10RA, IL10RB, STAT6 and TNFRSF18
genes have been investigated for possible association with
uncomplicated malaria and high P. falciparum parasite
density among Congolese children. These findings indicate
that the STAT6 promoter polymorphism rs3024944 is
highly associated with protection against uncomplicated
malaria, whereas the FOXP3 promoter variant rs11091253
is more likely to be involved in the control of P. falcip-
arum parasite density levels. In addition, a new SNP
detected in the promoter region of IL10RA (ss491228441)
contributes to protection against clinical malaria. These
findings deserve to be further investigated in a larger
population of children in the Republic of Congo but also
in other malaria endemic areas.
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